Seeker Biologics, a 5AM Ventures biotech led by ex-Translate Bio president, shuts down
Seeker Biologics, a Boston-based biotech startup formed out of 5AM Ventures to make new biologics, has shut down.
Seeker set out to make new medicines for autoimmune, allergic and inflammatory diseases and had secured a Series A financing, according to job postings and profile descriptions on LinkedIn.
“It can be challenging to witness a talented team dedicated to discovering new medicines fall short of their ambitious goals in a demanding market. However, science doesn’t always take us in the direction we expect, nor does it adhere to our timeline,” Jarrat Jordan, VP and head of biology at Seeker, wrote in a LinkedIn post on Thursday.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 170,200+ biopharma pros reading Endpoints daily — and it's free.